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ABSTRACT
Norovirus is a highly transmissible infectious agent that causes epidemic gastroenteritis in susceptible children and adults. No-
rovirus infections can be severe and can be initiated from an exceptionally small number of viral particles. Detailed genome se-
quence data are useful for tracking norovirus transmission and evolution. To address this need, we have developed a whole-ge-
nome deep-sequencing method that generates entire genome sequences from small amounts of clinical specimens. This novel
approach employs an algorithm for reverse transcription and PCR amplification primer design using all of the publically avail-
able norovirus sequence data. Deep sequencing and de novo assembly were used to generate norovirus genomes from a large set
of diarrheal patients attending three hospitals in Ho Chi Minh City, Vietnam, over a 2.5-year period. Positive-selection analysis
and direct examination of protein changes in the virus over time identified codons in the regions encoding proteins VP1, p48
(NS1-2), and p22 (NS4) under positive selection and expands the known targets of norovirus evolutionary pressure.
IMPORTANCE
The high transmissibility and rapid evolutionary rate of norovirus, combined with a short-lived host immune responses, are
thought to be the reasons why the virus causes the majority of pediatric viral diarrhea cases. The evolutionary patterns of this
RNA virus have been described in detail for only a portion of the virus genome and never for a virus from a detailed urban tropi-
cal setting. We provide a detailed sequence description of the noroviruses circulating in three Ho Chi Minh City hospitals over a
2.5-year period. This study identified patterns of virus change in known sites of host immune response and identified three addi-
tional regions of the virus genome under selection that were not previously recognized. In addition, the method described here
provides a robust full-genome sequencing platform for community-based virus surveillance.
Norovirus is a nonenveloped, positive-sense, single-strandedRNA virus approximately 7.5 to 7.7 kb in length (reviewed in
reference 1). The viral genome is organized into three (or four in
the case of murine norovirus [MNV] [2]) open reading frames
(ORFs) that encode several structural and nonstructural proteins.
ORF1 encodes a large polyprotein that is proteolytically cleaved
into six nonstructural proteins, including theN-terminal p48 pro-
tein (NS1-2), an NTPase (NS3), the 3A-like p22 protein (NS4),
the viral genome-linked VpG protein (NS5), the 3C-like protease
3CLpro (NS6), and the RNA-dependent RNA polymerase RdRp
(NS7).Note that the nomenclature for theNSproteins is currently
in flux, and both existing names have been included (3). ORF2
overlaps ORF1 by a short region and encodes the major capsid
proteinVP1, comprising an S (shell) domain connecting the twoP
(protruding) subdomains, P1 and P2, with the P2 domain binding
to histo-blood group antigens (HBGAs) on target host cells.
ORF3, located at the 3= end of the genome, encodes the minor
capsid protein VP2.
Norovirus is one of the genera in the Caliciviridae family of
viruses and can be further classified into different genogroups
(reviewed in reference 1).Noroviruses are known to cause diseases
in humans (genogroups GI, GII, and GIV) and a number of other
mammals and include porcine (GII), ovine/bovine (GIII), canine
(GIV), and murine (MNV, forming the distinct genogroup GV)
viruses (4–12).
In humans, norovirus is a highly infectious pathogen that
causes a severe gastrointestinal disease in susceptible individuals
after the ingestion of an exceptionally small number of viral par-
ticles. The virus is so infectious that the probability of symptom-
atic disease froma single norovirus virion has been estimated to be
as high as 0.5 (13). The dose required to infect 50% of test subjects
has been estimated to be 1,000 to 3,000 virus genome equivalents
(14). A typical norovirus infection can result in profuse volumes
of feces and vomitus containing 106 to 109 stable, nonenveloped
virions per milliliter of excreta, creating almost infinite opportu-
nities for onward transmission and additional infections. An in-
ability to culture human noroviruses in a laboratory prevents the
testing of inactivation and disinfectionmethods and further com-
plicates control efforts. These issues highlight some of the difficul-
ties in eliminating infectious norovirus from food supplies and the
environment and indicate the need for the development of intel-
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ligent approaches to prevent norovirus transmission and infec-
tion.
An effective approach to controlling norovirus may be to un-
derstand how norovirus evades the human immune system and
use this information to develop novel therapeutic options. Noro-
virus infection in a “healthy” individual is typically short and self-
limiting, which results in transient or short-lived immunity (15,
16). No approved drugs that block virus replication exist. Accord-
ingly, public health measures to identify and eliminate sources of
infection or behavior leading to virus spread are warranted (17,
18). The utility of viral sequencing to track norovirus in transmis-
sion studies has been explored with fragments of the viral genome
(19–22). As a consequence of the speed of disease onset and high
transmissibility, the number of nucleotide and amino acid se-
quence changes within a local outbreak may be rare, so the se-
quencing of larger genomic fragments should provide greater res-
olution for defining transmission patterns.
The natural duration and specificity of immune responses to
norovirus are difficult to measure because of the lack of a cell
culture system for norovirus neutralization studies and the inabil-
ity to grow a defined virus for such trials (reviewed in references 16
and 23). The duration of norovirus immunity may be limited by
the short period of a typical infection and a correspondingly short
exposure to viral antigens. Periodic population level replacement
of norovirus lineageswith viruseswith surface residues under pos-
itive selection is evidence of immune response-driven antigenic
change and suggests that these immune responses are of sufficient
strength to drive viral evolution (24–26). Immune studies have
identified blockade epitopes in VP1, the major capsid protein.
These epitopes are important for interaction with HBGAs on tar-
get host cells; high titers of antibodies that block virus-like particle
binding to HBGAs correlate with protection from a norovirus
challenge (27–29).
Diarrheal diseases are a serious health problem, especially in
developing countries when combined with nutritional problems,
coinfection with other pathogens, crowding, and limited access to
health care. It is clear that norovirus and rotavirus are frequently
associated with diarrhea in this setting (30), and it is essential to
closely follow the local evolution of norovirus. We describe here a
method for deep sequencing of the approximately 7,500-nucleo-
tide (nt) norovirus RNA genome directly from patient material
and use this method to provide a detailed description of genome-
and community-wide norovirus evolution.
MATERIALS AND METHODS
Primer design. Primers were designed by using Python algorithms to
identify highly conserved primer targets in the appropriate genome loca-
tions. Briefly, the algorithm takes as input all of the complete human
norovirus genome sequences available in the GenBank database (January
2012, 260 GII.4 entries, 5 GI entries; total sequence, 1.9  106 nt). A
counting method was employed to identify all of the highly conserved
primer-like sequences with GC percentages between 30 and 75%, cal-
culated melting temperatures (Tms) between 55 and 59°C, and no single
nucleotide comprising greater than 40% of the sequence. The norovirus
genome was divided into three overlapping 2.5- to 3-kb amplicons, and
the highest-frequency primer sites in the first and last 800 nt of each
amplicon were selected. Finally the primers were used in a virtual PCR to
determine the binding behavior of the primer set with all of the available
full norovirus genomes (see Fig. 1). Primer details are summarized in
Table 1.
Sample collection. Stool samples were obtained as part of a larger
study examining causes of pediatric diarrhea in subjects presenting to
Children’sHospital 1, Children’sHospital 2, and theHospital for Tropical
Diseases, Ho ChiMinh City (HCMC), Vietnam (30, 31). Additional sam-
ples came from an ad hoc enrollment of children admitted to Children’s
Hospital 2 with potentially hospital-acquired norovirus diarrhea or pro-
longed norovirus incubation. In the ad hoc collection, pediatric patients
were admitted to the hospital because of diseases other than diarrheal
diseases and had no diarrhea when they arrived at the hospital. The group
included only patients who developed diarrhea after at least 48 h of hos-
TABLE 1 Primers used in this study
Primer Sequence Strand Positiona Tm
b GC_fraction
Norovirus GII
genomes (517)c
Norovirus genomes
(753)f
0 MMd 0–3 MMe 0 MMg 0–3 MMh
UNP_47 GTGAATGAAGATGGCGTCTAAC Plus 1 55.52 0.45 98 100 83 84
UNP_45 TCTAACGACGCTTCCGCTG Plus 17 58.30 0.58 75 96 62 80
UNP_201R GCAATGGCCACCTCCTCAT Minus 2808 57.95 0.58 97 100 80 85
UNP_226R TTGGCCTCCTCCTCTTCACA Minus 2850 58.21 0.55 92 99 76 82
UNP_339 GGCAAGAAGCACACAGCC Plus 2660 57.48 0.61 88 92 73 78
UNP_1316 TGGTCCAAGCCACAAGTGG Plus 2519 58.05 0.58 11 100 13 89
UNP_82 GACCTCTGGGACGAGGTTG Minus 5150 57.41 0.63 87 96 70 80
UNP_135 CTCCACCAGGGGCTTGTAC Minus 5271 57.63 0.63 89 94 73 78
UNP_2 GGGAGGGCGATCGCAAT Plus 5049 57.57 0.65 88 96 72 79
UNP_23 TTGTGAATGAAGATGGCGTCGA Plus 5079 58.53 0.45 56 100 42 84
UNP_100 GCCAGTCCAGGAGTCCAA Minus 7447 56.43 0.61 74 97 61 83
UNP_44 GCACGGTTGAGACTGTGC Minus 7418 57.27 0.61 84 98 69 82
UNP_20 CGAGGGGAGTCACGGGT Minus 7493 58.34 0.71 86 97 70 83
a Primer mapping position in the norovirus GII.4 genome (GenBank accession no. JQ613552).
b The Tm was calculated with a Python script that approximates the Breslauer method (59).
c All GenBank database entries (July 2014) for norovirus GII (taxonomic identification no. 142786; length, 7,000 to 8,000 nt; 517 entries).
d Percentage of norovirus GII genomes (n 517) showing perfect homology to the primer.
e Percentage of norovirus GII genomes (n 517) showing the target sequence for the primer with up to three mismatches.
f All GenBank database entries (July 2014) for norovirus (taxonomic identification no. 122929; length, 7,000 to 8,000 nt; 753 entries).
g Percentage of norovirus genomes (n 753) showing perfect homology to the primer.
h Percentage of norovirus genomes (n 753) showing the target sequence for the primer with up to three mismatches.
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pitalization, with the diarrhea lasting at least 3 days after onset. Ethical
approval was granted by the institutional ethical review boards and the
University of Oxford Tropical Research Ethics Committee (OxTREC no.
0109).
Generation of amplified cDNA for deep sequencing. For RNA ex-
traction, 140 l of each stool specimen was subjected to automated ex-
traction into a final 50-l elution with the MagNA Pure 96 automated
extraction machine according to the manufacturer’s instructions
(Roche). Reverse transcription (RT) was performed as previously de-
scribed (32). Briefly, a primer mixture was prepared separately for each
amplicon; the reverse primers for the amplicon were pooled in an
equimolar ratio and water added up to 7 l of the primer mixture (7.6
pmol of each primer; 0.38 pmol/l per reaction mixture). Extracted no-
rovirus RNA was diluted 1:10 in water; 5 l of this dilution was added to
TABLE 2 GenBank and ENA accession numbers, genetic cluster, and
sample collection date
Virus
GenBank
accession
no.a
ENA
accession
no.b Clusterc
Sample
collection
dated
Hu_GII_10116_2009_VNM KM198480 ERR212491 1 9/7/2009
Hu_GII_10054_2009_VNM KM198481 ERR225641 1 21/5/2009
Hu_GII_10114_2009_VNM KM198482 ERR212490 1 9/7/2009
Hu_GII_10313_2010_VNM KM198483 ERR217285 4 22/2/2010
Hu_GII_30212_2009_VNM KM198484 ERR223539 5 6/10/2009
Hu_GII_10148_2009_VNM KM198485 ERR212498 2 11/8/2009
Hu_GII_C2H-18_2011_VNM KM198486 ERR225628 3 30/8/2011
Hu_GII_10110_2009_VNM KM198487 ERR212489 1 6/7/2009
Hu_GII_10325_2010_VNM KM198488 ERR217290 4 26/2/2010
Hu_GII_10101_2009_VNM KM198489 ERR212487 1 25/6/2009
Hu_GII_10002_2009_VNM KM198490 ERR225635 1 4/5/2009
Hu_GII_30351_2009_VNM KM198491 ERR138007 4 17/12/2009
Hu_GII_30448_2010_VNM KM198492 ERR223547 6 29/1/2010
Hu_GII_30468_2010_VNM KM198493 ERR223549 5 24/2/2010
Hu_GII_10247_2009_VNM KM198494 ERR217278 1 10/12/2009
Hu_GII_10193_2009_VNM KM198495 ERR138002 1 05/10/2009
Hu_GII_20419_2010_VNM KM198496 ERR223554 5 1/2/2010
Hu_GII_10236_2009_VNM KM198497 ERR217280 1 19/11/2009
Hu_GII_20088_2009_VNM KM198498 ERR223553 8 28/7/2009
Hu_GII_20118_2009_VNM KM198499 ERR212481 1 28/8/2009
Hu_GII_C2H-20_2011_VNM KM198500 ERR225629 5 5/9/2011
Hu_GII_10173_2009_VNM KM198501 ERR212503 1 11/9/2009
Hu_GII_10136_2009_VNM KM198502 ERR212495 1 3/8/2009
Hu_GII_C2033_2010_VNM KM198503 ERR212484 6 28/6/2010
Hu_GII_20151_2009_VNM KM198504 ERR212467 1 16/9/2009
Hu_GII_20460_2010_VNM KM198505 ERR223530 5 4/3/2010
Hu_GII_10199_2009_VNM KM198506 ERR217283 1 20/10/2009
Hu_GII_C2007_2010_VNM KM198507 ERR138011 4 2/4/2010
Hu_GII_20066_2009_VNM KM198508 ERR212470 1 14/7/2009
Hu_GII_20479_2010_VNM KM198509 ERR223531 5 16/3/2010
Hu_GII_10012_2009_VNM KM198510 ERR225637 1 7/5/2009
Hu_GII_C2H-24_2011_VNM KM198511 ERR225631 5 16/9/2011
Hu_GII_10062_2009_VNM KM198512 ERR225642 1 29/5/2009
Hu_GII_20494_2010_VNM KM198513 ERR223534 1 19/3/2010
Hu_GII_10079_2009_VNM KM198514 ERR212486 1 11/6/2009
Hu_GII_C2H-31_2011_VNM KM198515 ERR217269 3 28/9/2011
Hu_GII_10285_2010_VNM KM198516 ERR217288 4 18/1/2010
Hu_GII_30399_2010_VNM KM198517 ERR138008 1 11/1/2010
Hu_GII_10182_2009_VNM KM198518 ERR212507 1 17/9/2009
Hu_GII_30082_2009_VNM KM198519 ERR223537 8 23/6/2009
Hu_GII_10158_2009_VNM KM198520 ERR212499 1 21/8/2009
Hu_GII_10176_2009_VNM KM198521 ERR212504 1 14/9/2009
Hu_GII_20150_2009_VNM KM198522 ERR212466 1 15/9/2009
Hu_GII_10204_2009_VNM KM198523 ERR217287 1 29/10/2009
Hu_GII_10034_2009_VNM KM198524 ERR225638 1 15/5/2009
Hu_GII_10163_2009_VNM KM198525 ERR212501 1 28/8/2009
Hu_GII_10075_2009_VNM KM198526 ERR225644 1 9/6/2009
Hu_GII_10074_2009_VNM KM198527 ERR225643 1 9/6/2009
Hu_GII_C2H-25_2011_VNM KM198528 ERR225632 5 20/9/2011
Hu_GII_C2H-27_2011_VNM KM198529 ERR225633 5 21/9/2011
Hu_GII_20486_2010_VNM KM198530 ERR223532 7 18/3/2010
Hu_GII_30116_2009_VNM KM198531 ERR223538 7 9/7/2009
Hu_GII_10108_2009_VNM KM198532 ERR212488 1 2/7/2009
Hu_GII_30241_2009_VNM KM198533 ERR223540 1 26/10/2009
Hu_GII_30443_2010_VNM KM198534 ERR223546 8 28/1/2010
Hu_GII_20092_2009_VNM KM198535 ERR212474 1 31/7/2009
Hu_GII_20079_2009_VNM KM198536 ERR212473 1 24/7/2009
Hu_GII_10137_2009_VNM KM198537 ERR212496 1 4/8/2009
Hu_GII_10051_2009_VNM KM198538 ERR225640 1 21/5/2009
Hu_GII_C2H-36_2011_VNM KM198539 ERR217266 3 25/10/2011
Hu_GII_20145_2009_VNM KM198540 ERR212464 1 11/9/2009
Hu_GII_20188_2009_VNM KM198541 ERR138004 1 7/10/2009
Hu_GII_20094_2009_VNM KM198542 ERR212476 2 3/8/2009
Hu_GII_20357_2009_VNM KM198543 ERR138005 4 30/12/2009
Hu_GII_C2418_2010_VNM KM198544 ERR138012 4 1/11/2010
Hu_GII_10195_2009_VNM KM198545 ERR217284 1 13/10/2009
Hu_GII_20067_2009_VNM KM198546 ERR212471 1 15/7/2009
TABLE 2 (Continued)
Virus
GenBank
accession
no.a
ENA
accession
no.b Clusterc
Sample
collection
dated
Hu_GII_C2H-47_2011_VNM KM198547 ERR217275 5 3/11/2011
Hu_GII_20107_2009_VNM KM198548 ERR212477 1 20/8/2009
Hu_GII_30473_2010_VNM KM198549 ERR223550 7 1/3/2010
Hu_GII_10078_2009_VNM KM198550 ERR225645 1 10/6/2009
Hu_GII_20108_2009_VNM KM198551 ERR212478 1 20/8/2009
Hu_GII_20154_2009_VNM KM198552 ERR212469 1 16/9/2009
Hu_GII_30381_2010_VNM KM198553 ERR223544 5 4/1/2010
Hu_GII_C2H-48_2011_VNM KM198554 ERR217271 5 4/11/2011
Hu_GII_C2035_2010_VNM KM198555 ERR138006 4 28/6/2010
Hu_GII_10127_2009_VNM KM198556 ERR212492 1 17/7/2009
Hu_GII_10194_2009_VNM KM198557 ERR217286 1 13/10/2009
Hu_GII_30257_2009_VNM KM198558 ERR223541 1 30/10/2009
Hu_GII_10129_2009_VNM KM198559 ERR212493 1 20/7/2009
Hu_GII_C2H-50_2011_VNM KM198560 ERR217268 3 22/11/2011
Hu_GII_30303_2009_VNM KM198561 ERR223542 5 23/11/2009
Hu_GII_C2H-55_2011_VNM KM198562 ERR212509 3 25/11/2011
Hu_GII_C2365_2010_VNM KM198563 ERR212485 5 15/9/2010
Hu_GII_C2H-44_2011_VNM KM198564 ERR217276 3 31/10/2011
Hu_GII_10169_2009_VNM KM198565 ERR212502 1 4/9/2009
Hu_GII_20093_2009_VNM KM198566 ERR212475 1 3/8/2009
Hu_GII_10255_2009_VNM KM198567 ERR217273 1 15/12/2009
Hu_GII_C2H-62_2011_VNM KM198568 ERR217267 3 14/12/2011
Hu_GII_10235_2009_VNM KM198569 ERR217274 1 19/11/2009
Hu_GII_20146_2009_VNM KM198570 ERR212465 1 11/9/2009
Hu_GII_20123_2009_VNM KM198571 ERR212479 1 1/9/2009
Hu_GII_20370_2010_VNM KM198572 ERR212461 5 6/1/2010
Hu_GII_C2H-45_2011_VNM KM198573 ERR217277 5 2/11/2011
Hu_GII_10183_2009_VNM KM198574 ERR217289 1 22/9/2009
Hu_GII_20069_2009_VNM KM198575 ERR212472 1 16/7/2009
Hu_GII_C2H-43_2011_VNM KM198576 ERR217281 3 14/10/2011
Hu_GII_10145_2009_VNM KM198577 ERR212497 1 7/8/2009
Hu_GII_C2H-52_2011_VNM KM198578 ERR212508 3 24/11/2011
Hu_GII_10160_2009_VNM KM198579 ERR212500 1 26/8/2009
Hu_GII_10223_2009_VNM KM198580 ERR217272 1 6/11/2009
Hu_GII_10003_2009_VNM KM198581 ERR225636 1 5/5/2009
Hu_GII_30192_2010_VNM KM198582 ERR138003 1 21/9/2009
Hu_GII_20493_2010_VNM KM198583 ERR223533 5 19/3/2010
Hu_GII_10131_2009_VNM KM198584 ERR212494 1 22/7/2009
Hu_GII_10238_2009_VNM KM198585 ERR217282 1 19/11/2009
Hu_GII_30400_2010_VNM KM198586 ERR223545 5 11/1/2010
Hu_GII_20153_2009_VNM KM198587 ERR212468 1 16/9/2009
Hu_GII_10037_2009_VNM KM198588 ERR225639 1 15/5/2009
Hu_GII_20144_2009_VNM KM198589 ERR212463 1 10/9/2009
Hu_GII_C2H-39_2011_VNM KM198590 ERR217270 5 24/10/2011
Hu_GII_20122_2009_VNM KM198591 ERR212480 1 31/8/2009
a GenBank accession number, accessible at http://www.ncbi.nlm.nih.gov/nuccore/.
b European Nucleotide Archive (ENA) accession number, accessible at http://www.ebi
.ac.uk/ena/.
c Genetic cluster as defined in Fig. 2.
d Day/month/year of sample collection.
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the primer mixture, which was heated for 5 min at 65°C and immediately
transferred to an ice block for 1 min. An enzyme mixture was then added
to each reaction mixture and mixed by pipetting. Each 20-l reaction
mixture contained 4 l of 5 First Strand buffer (250 mM Tris-HCl [pH
8.3], 375 mMKCl, 15 mMMgCl2), 1l of 0.1 M dithiothreitol, 1l of 10
mM deoxynucleoside triphosphates, 1 l of RNase Inhibitor (40 U/l;
Promega), and 1l of SuperScript III reverse transcriptase (200U/l; Life
Technologies). RT was performed at 50°C for 60 min, followed by 70°C
for 15 min.
PCR amplification. Amplification was performed with primer mix-
ture solutions prepared for each amplicon. For the primer mixture (per
25-l reaction mixture), the forward and reverse primers from each am-
plicon were pooled in a 1.5:1 ratio (1.9 pmol of each forward primer and
1.26 pmol of each reverse primer; 0.08 pmol/l and 0.05 pmol/l, respec-
tively). A 5-l aliquot of the RT reaction mixture for each amplicon was
used as the template for the PCR step. The thermal cycling conditions
used were enzyme activation at 98°C for 30 s; 35 cycles of 98°C for 10 s,
53°C for 30 s, and 72°C for 3.0 min; a final extension at 72°C for 10 min;
and holding at 4°C.
Sequencing and genome assembly. Pooled amplicons for each sam-
ple (approximately 1.2 g) were individually indexed and subjected to
sequencing with Illumina MiSeq (33, 34) to generate approximately
300,000 reads of 149 nt per sample (median value, 302,904 reads). All
reads were processed with QUASR (35) to remove sequencing adapters
and index sequences and to trim primer sequences present within a fixed
distance of the 5= or 3= end of a read. Reads were then trimmed from the 3=
end to reach a minimum median Phred quality score of 35, and reads
125 nt in length were removed. After primer trimming and quality
control for each sample, de novo assembly with SPAdes (36) was used to
generate full norovirus genomes. Intact ORFs were checked with Python
scripts as a measure of correct genome assembly.
Recombination detection.The 119 complete genomes of all of theGII
noroviruses from this study and from global data (retrieved from the
GenBank database) were manually aligned with Se-AL v2.0 (http://tree
.bio.ed.ac.uk/software/seal/). Only full-length sequences with informa-
tion on the sample collection date and location were included in this
analysis. The potential presence of recombination in these complete se-
quences was screened for with the Recombination Detection Program
version 4 (RDP4) software (37). The RDP, GENECONV, 3SEQ, and
MAXCHI methods were employed for primary screening, and the
BOOTSCAN and SISCAN methods were used for automatic checking of
the recombination signals, as described previously (38). The automask X
function in RDP4 was selected for optimal recombination detection; i.e.,
one representative strain within each group of similar sequences was ex-
amined during the primary/exploratory search for recombination signals
while the remaining sequences within groups of sequences with high sim-
ilarity were automatically masked. By this method, masked sequences
were examined for the presence of recombination if the program detected
a recombination signal in the representative unmasked sequence. Each
test of recombination used a 400-nt sliding window, and any recombina-
tion signals with significant P values for three or more test parameters
were considered potential recombination events. A further analysis of
these potential recombinants, comparing tree topologies with likelihood
(Shimodaira-Hasegawa test) was employed to determine which of the test
strains were likely to be true recombinants and which were not. All intra-
ORF recombinant strains (GenBank accession numbers EU921388,
AB541275, GU991355, and AB541254) were excluded from the estima-
tion of positive selection and evolutionary rates.
Phylogenetic analysis. An alignment of nonrecombinant sequences
including all of the full genomes determined in this analysis and global
background sequences obtained from the GenBank database was utilized
to reconstruct evolutionary relationships among norovirus sequences. A
phylogenetic tree was inferred by using aligned nucleotide sequences, em-
ploying a maximum-likelihood (ML) method in RaxML (39) under the
GTR model of substitution, which was determined to be the model
that fit our data best with jModelTest version 2.1.1 (40). Tree topology
was assessed through bootstrapping with 1,000 pseudoreplicates. The re-
sulting phylogenetic tree was visualized and edited in FigTree v1.4.0 (http:
//tree.bio.ed.ac.uk/software/figtree/).
Evolutionary-rate estimations. Evolutionary rates were estimated by
a Bayesian Markov chain Monte Carlo (BMCMC) method implemented
in BEAST version 1.7.2 (41). A relaxed uncorrelated lognormalmolecular
clock was employed to account for lineage-specific rates, and a GMRF
Bayesian skyride coalescent (42) was used to model the population dy-
namics. The relevant substitution models for each alignment were se-
lectedwith jModelTest version 2.1.1 (40). Themean evolutionary rate and
the 95% upper and lower highest posterior density (HPD) intervals were
inferred from the posterior tree distribution generated from the BMCMC
runs with Tracer version 1.6 (http://tree.bio.ed.ac.uk/software/tracer/).
Positive-selection analysis. To determine evolutionary patterns of
norovirus, selection analyses of the regions encoding VP1, VP2, and the
ORF1-encoded p48 (NS1-2) and p22 (NS4) proteins were performed.
Norovirus codons under selective pressure were first determined with the
mixed-effects model of evolution (MEME; P value,0.05) (43) and fast
FIG 1 Primer design and function for full-genome deep-sequencing amplification. (Left panel) Virtual PCR showing the mapping of the designed primers to a
norovirus GII.4 genome (GenBank accession no. JQ613552). Colored circles indicate the position of each primer and the number of mismatches; gray bars
indicate the predicted sizes of the PCR products. A schematic of the ORF organization of the virus is shown at the top. (Right panel) The PCR products from 14
samples for individual primer pairs for amplicons 1, 2, and 3. Amplification of sample 7 failed. Lanes: c, water control;m, sizemarker. The sizes of relevantmarker
bands (in kilobase pairs) are indicated to the right.
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unconstrained Bayesian approximation (FUBAR; posterior probability,
0.9) (44) implemented through the DataMonkey web browser (45).
Codons that were found to be under positive selection by either method
were inspected at the sequence alignment, and those with no evidence of
polymorphisms were considered false positive and discarded.
Ancestral sequences were reconstructed from the sequence alignment
and inferred phylogeny by the joint-likelihood method implemented in
HyPhy (46) under a GTRmodel of evolution.
Nucleotide sequence accession numbers. The GenBank accession
numbers of all of the new norovirus sequences reported here are listed in
Table 2. Also listed are the sample collection dates, the genetic clusters (see
Fig. 2 and Table 4), and the EuropeanNucleotide Archive accession num-
bers of the raw sequence data. In addition, 89 GII.4 genomes from the
sameHCMC study are publically available in the GenBank database, with
the following accession numbers: cluster 1, KC409244, KC409245,
KC409246,KC409257, KC409258, KC409259, KC409260, KC409261,
KC409262, KC409264, KC409265, KC409266, KC409267, KC409268,
KC409269, KC409270, KC409271, KC409272, KC409273, KC409274,
KC409275, KC409276, KC409277, KC409279, KC409280, KC409281,
KC409282, KC409283, KC409284, KC409285, KC409286, KC409287,
KC409288, KC409289, KC409290, KC409291, KC409293, KC409294,
KC409295, KC409296, KC409297, KC409298, KC409304, KC409305,
KC409306, KC409307, KC409308, KC409309, KC409310, KC409312,
KC409313, KC409314, KC409315, KC409318, KC175360, KC175365,
TABLE 3 PCR and genome sequencing success by norovirus genotype
Genotypea No. of samples Amplicon 1b Amplicon 2b Amplicon 3b No. of genomesc (%) Successful
GII.4 60 55 55 57 55 92
GII (non-GII.4) 58 48 45 53 45 74
GI 10 7 4 4 2 20
GII.2 5 4 1 5 2 40
GII.3 34 26 27 27 26 77
GII.6 8 8 7 8 7 88
GII.7 2 2 0 2 0 0
GII.9 1 1 0 1 1 100
GII.12 2 1 2 2 1 50
GII.13 6 5 6 6 5 83
a Sample genotype previously determined (30, 31).
b Successful RT-PCR amplification of sufficient DNA (ca. 0.4 g) for Illumina library preparation. The values shown are the number of successful amplicons generated.
c Yield of95% of the full genome.
FIG2 MLphylogenetic tree of the 112HCMCGII genomes in this study and 89GII.4 genomes from the sameHCMCcohort that were sequenced separately and
made publically available in theGenBank database plus selected global reference genomes. The eight phylogenetic clusters of norovirus identified in this study are
marked with colored bars. Bootstrap support of0.85 at key nodes is indicated with asterisks. The tree is midpoint rooted for clarity, and all horizontal branch
lengths are drawn to a scale of nucleotide substitutions per site.
Cotten et al.
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KC175366, KC175371, KC175373, KC175381, KC175388, KC175389,
KC175390, KC175391, KC175392, KC175393, KC175394, KC175395,
KC175396, KC175406, KC175407, KC175408, KC175409, and
KC175410; cluster 3, KC409256, KC409263, and KC409278; cluster 4,
KC409240, KC409241, KC409242, KC409243, KC409299, KC409301,
KC409302, KC409303, KC175384, KC175385, KC175386, and
KC175387.
RESULTS
Norovirus sequencing strategy. A novel general strategy for de-
signing PCR primers was developed that would permit the pro-
duction of complete norovirus genome sequences. Deep sequenc-
ing of RNA virus genomes requires RT of viral RNA and
amplification of the resulting cDNA, which encompasses the en-
tire viral genome. Python algorithms were used to process all of
the available norovirus full-genome data (265 full genomes, Jan-
uary 2012) and to select primer target sequences suitable for
whole-genome amplification. Briefly the algorithm processes the
norovirus sequence data into primer-sized sequences trimmed to
a calculatedTm. The frequency of each sequence in the entire set is
calculated, with high-frequency sequences correlating with con-
served sites across the viral genome. The norovirus genome was
divided into three overlapping amplicons, potential primers were
mapped to a reference genome, and the highest-frequency se-
quences mapping within the terminal 800 nt of each amplicon
were identified. Reverse complements of the primers mapping to
the 3= end were prepared. A virtual PCR was performed to exam-
ine the potential function of the primers across all known full
norovirus genomes. The output of such an analysis is shown in the
left panel of Fig. 1, with blue markers indicating the position of
each primer and gray bars indicating the expected PCR product.
The actual function of the primer set is demonstrated in the right
panel of Fig. 1, with each lane showing the PCR products from 14
samples, present by amplicon. Each RT reaction mixture con-
tained two (or three for amplicon 3) reverse primers each for
amplicon 1, 2, or 3, and each PCRmixture contained two (or three
for amplicon 3) forward and reverse primers for amplicon 1, 2, or
3. Of these samples, no. 7 failed; however, the remaining 13 sam-
ples provided sufficient material for deep sequencing.
A summary of the predicted performance of the norovirus
primer set with all of the available norovirus genomes is shown in
Table 1. All full-length norovirus GII genomes (taxonomic iden-
tification no. 142786; length, 7,000 to 8,000 nt; 517 entries) or all
norovirus genomes (taxonomic identification no. 122929; length
7,000 to 8,000 nt; 753 entries) were retrieved from the GenBank
database. These genome sets were examined for the target se-
quence for each primer, and the percentage of genomes with a
perfect match to the target sequence or with a functional match
(zero to three mismatches) to the target sequence was reported.
For the norovirus GII genomes, the primers have a perfect match
to 79% of the genomes and a functional match (up to 3 mis-
matches) to 97% of the genomes. For the complete set of norovi-
rus genomes (this includes all GI, all GII, and all animal norovi-
ruses), the primers have a perfect match to 65% of the genomes
and a functional match (zero to three mismatches) to 82% of the
genomes. These values and the details of the analysis, as well as the
GC contents and calculated Tms for all of the primers, are listed in
Table 1.
A summary of the performance of the norovirus primer set for
amplifying and sequencing 188 fecal sample-derived RNAs is pre-
sented in Table 3. PCR success was defined as obtaining the three
amplicon-specific RT-PCR products of the predicted size with
sufficient yield for sequencing library preparation. The overall
RT-PCR success rate was 78.2% (147 of the 188 clinical samples
tested). Themost common genotype globally, GII.4, had the high-
est PCR success rate (93.7%, 74 of 79 samples), followed by GII.6
(88%, 7 of 8 samples), GII.13 (83%, 5 of 6 samples), and GII.3
(77%, 26 of 34 samples). Much lower amplification efficiency was
observed for GI strains, with successful PCR genome amplifica-
tion in only 2 of 10 samples tested. The high success with GII with
respect to GI strains (especially GII.4) was predicable given that
GII.4 genomes dominate the sequences in public databases. Fu-
ture primer sets could be reiteratively designed by using targeted
and revised genome data sets.
Norovirus diversity in HCMC. By using the whole-genome
sequencing technique developed, 112 novel GII norovirus
genomic sequences were generated. In addition, 89GII.4 genomes
from the same HCMC study were also publically available in the
GenBank database; these were included in the following analysis
for a total of 201 complete genomes with collection dates between
April 2009 andDecember 2011. A phylogenetic analysis of the 201
genomes defined eight genotypes ofGII norovirus byMLmethods
(Fig. 2). Consistent with previous characterization of norovirus
TABLE 4 Phylogenetic clusters identified in this study
Phylogenetic
clustera Closest genomeb
Genotype by RIVM
algorithmc
No. of
genomes
Frequency (%) in
201 genomes
1 NV_GII_VNM_2009_KC175360 GII.P4.DH06b_GII.4.DH06b 140 69.65 (67.6)d
NV_GII_VNM_2009_KC175395
2 NV_GII_VNM_2009_KC175402 GII.P4.DH06b_GII.4.DH06b 2
3 NV_GII4_TW_2007_JN400615 GII.P4.DH06b_GII.4.DH06b 12
NV_GII4_Ehime_2007_AB541241
4 NV_GII_VNM_2010_KC175383 GII.P4.NO09_GII.4.NO09 20 9.95 (9.5)
5 NV_Pune_2007_EU921389 GII.P21_GII.3 19 9.45 (10.2)
6 NV_Pune_2007_EU921389 GII.Pg_GII.12 2 0.99 (0.6)
NV_GII2_12_Wahroonga_2009_JQ613568
7 NV_GII_Gifu_1999_AB084071 (50%) GII.P7_GII.6 3 1.49 (2.5)
8 NV_GII_Gifu_1999_AB084071 (50%) GII.P7_GII.6 3 1.49 (2.5)
a Phylogenetic classification (see Fig. 2).
b Based on the number of reads mapped.
c Based on the RIVM algorithm (47).
d The values in parentheses are genotype frequency percentages determined by My et al. (31).
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infections in HCMC (30) and global norovirus patterns, the most
prevalent GII.4 genotype found in this study belonged to the GII.4
Den Haag lineage (Fig. 2, clusters 1, 2, and 3), which is most
genetically similar to the GII.4 Minerva_2006b partial sequence
and Taiwan_2006 (GenBank accession no. JN400601). Phyloge-
netically, the GII.4 strains in cluster 4 (Fig. 2A) were most closely
related to GII.4 New_Orleans_2010 (GenBank accession no.
JN595867), while the GII strains in cluster 5 were classified as
GII.P21_GII.3 and most closely related to strain NV_Pune_2007
(GenBank accession no. EU921389). A small number of strains
belonged to genotype GII.Pg_GII.12 (cluster 6), while viruses of
theGII.P7_GII.6 genotype fell into two distinct lineages, clusters 7
and 8 (Fig. 2). Our genotype assignment based on phylogenetic
reconstruction was consistent with the genotype designation gen-
erated by the RIVM algorithm (47) (Table 4). Additionally, the
relative frequency of each genotype observed in the full genome
set was similar to the frequencies determined by My et al. (31)
from a larger set of HCMC samples with ORF1 and -2 fragments
(Table 4), indicating that the generation of full genome sequences
was not strongly influenced by genotype-based selection biases.
Viruses of the GII.4 DenHaag andGII.P21/GII.3 genotypes (clus-
ters 1 and 5)were identified in two sampling periods, in 2009-2010
and later in 2011, while the other virus genotypes were detected
only in the first sampling period.
The temporal occurrence of sampled noroviruses is shown in
Fig. 3, with samples stratified by genotype cluster. The three
GII.P4/GII.4(2006) genotypes (clusters 1, 2, and 3) were present
in the first half of 2009, with the GII.P4/GII.4(2010) genotype
(cluster 4, gray) first appearing at the end of 2009. There was a
pause in sampling in the first half of 2011, followed by sampling in
the second half of 2011. Reduced diversity was observed in 2011,
with only clusters 3 and 5 sequenced from these samples. Changes
in sampling protocols between 2010 and 2011 preclude inference
of how this reduced diversity may relate to norovirus epidemiol-
ogy and evolution. However, the identification of clusters of phy-
logenetically related viruses undergoing in situ evolution in this
region over the observation period allowed an examination of
evolutionary processes thatmay allow the continued transmission
and maintenance of viral lineages in the presence of population
immune responses. Characterization of such changes in the noro-
virus population may provide important clues about how the vi-
rus evades host immunity.
Evolutionary rateswithin each cluster.Asufficient number of
genomes were available from clusters 1, 4, and 5 for well-sup-
ported evolutionary-rate estimations (Table 5). Mean evolution-
ary rates of 6.15 10	3, 5.73 10	3, and 5.34 10	3 substitu-
tion per site per year were estimated from the full genomes of
clusters 1, 4, and 5. Figure 4 plots the rates for the GII.4 cluster 1
viruses by the region of the genome used for each calculation.
The ORF-specific rates estimated for the three genetic clusters
show that the ORF1 regions exhibited a lower rate than those of
the ORF2 (VP1) regions. For all three clusters, the ORF1 and
ORF2 (VP1) regions showed rates modestly lower than that of the
FIG 3 Temporal appearance of the HCMC norovirus GII genotypes during the study period. Genomes were stratified by genotype (from Fig. 2), color coded,
and plotted by date of sample isolation.
TABLE 5 Evolutionary rates
Sequence set and genomic region
Mean rate
(95% HPD)a
Substitution
model
Cluster 1, GII.P4 Den Haag 2006b_GII.4
Den Haag 2006b
Whole genome 6.15 (5.39–6.86) SRD06
ORF1 5.94 (5.04–6.94) SRD06
ORF2 5.69 (4.54–6.90) SRD06
ORF3 8.99 (6.59–11.6) SRD06
p48 (NS1-2) 6.60 (4.83–8.47) GTRG
NTPase (NS3) 5.41 (4.04–6.89) GTRG
p22 (NS4) 8.21 (5.48–11.11) GTRG
VPg (NS5) 5.95 (3.27–8.94) HKYG
3CLpro (NS6) 6.03 (3.57–8.61) GTRG
RdRp (NS7) 4.74 (3.50–6.10) GTRG
Cluster 4, GII.P4 New Orleans 2009_GII.4
New Orleans 2009
Whole genome 5.73 (3.74–7.81) GTRG
ORF1 4.03 (1.77–6.33) HKYG
ORF2 5.60 (0.68–9.82) HKYG
ORF3b
Cluster 5, GII.P21_GII.3
Whole genome 5.34 (4.06–6.82) SRD06
ORF1 4.81 (3.45–6.17) SRD06
ORF2 5.99 (3.75–8.39) SRD06
ORF3 7.38 (2.06–13.9) SRD06
a Evolutionary rates were measured as 10	3 substitution per site per year. The mean
evolutionary rate (10	3 substitution per site per year) and the 95% upper and lower
HPD intervals were determined as described in Materials and Methods.
b There was insufficient signal for the algorithms to return a reliable evolutionary rate
for ORF3 region of sequences from GII.4 cluster 4.
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full genome,while theORF3 (VP2) substitution rates of both clus-
ter 1 (8.99  10	3 substitution per site per year) and cluster 5
viruses (7.38  10	3 substitution per site per year) were higher
than that of the whole genome. The overlapping confidence inter-
vals for these estimations make these conclusions less secure. The
amount of signal available for cluster 4 ORF3 was not sufficient to
yield a reliable rate estimate.
Norovirus ORF1 encodes a large polyprotein containing the
viral polymerase and protease and several essential replicase com-
ponents. Evolutionary rates were estimated separately for these
individual coding regions of cluster 1 ORF1 (Table 5; Fig. 4). The
region encoding p22 (NS4) showed the highest levels of change
(6.60 10	3 and 8.21 10	3 substitution per site per year, Fig.
4), greater than the whole-genome rates for cluster 1 (6.15 10	3
substitution per site per year). The enzymes (NTPase [NS3], pro-
tease, andRdRp [NS7]) andVP1 show substitution ratesmodestly
lower than those observed across the whole genome.
Amino acid changes in norovirus proteins. The evolutionary
patterns of four norovirus-encoded proteins with the higher evo-
lutionary rates were examined (VP1, VP2, p48 [NS1-2], and p22
[NS4]). An alignment of protein sequences ordered by time was
used to detect sustained versus sporadic changes in the protein
relative to a reconstructed ancestral sequence. Information about
the biochemical properties of the protein was gathered from the
published literature. Positive-selection analysis was performed
with MEME (43) or FUBAR (44).
Cluster 1 VP1 showed changes in multiple patients relative to
the ancestral sequence, i.e., Q106R, S174P, and N298D in block-
ade epitope A and G340E and G393S in blockade epitope D (Fig.
5). Additional substitutions were seen at a lower frequency, sug-
gesting evolution during the course of transmission through
HCMC. Position 298 in blockade epitope A was found to be pos-
itively selected with FUBAR, while both FUBAR andMEME iden-
tified position 106 within the shell domain (Fig. 5) as being under
positive selection (Table 6).
An alignment of VP2 protein sequences ordered by time was
used to detect sustained versus sporadic changes in the protein
relative to the ancestral sequence. Several changes, including
T139M/A, I144V/T, and Y169H, occurred in multiple HCMC
cluster 1 viruses with a much higher frequency of changes in the
internal region of the protein (Fig. 6). It was previously noted that
changes in this region of VP2 (VP1-interacting domain [VP_ID])
were associated with changes in VP1 (48). Both MEME and
FUBAR identified VP2 codon 144 (marked with a red asterisk in
Fig. 6) as being under positive selection.
The region encoding p22 (NS4) from the cluster 1 viruses
showed higher evolutionary rates than the full genome (Table 5;
Fig. 4). Analysis of all of the encoded p22 (NS4) molecules from
cluster 1 (Fig. 7) showed amino acid differences from the ancestral
sequence. Substitutions were observed in multiple isolates, sug-
gesting neutral or positive selection (I29V, E46D, N77S, R82K,
T86S, and D174V). Analysis of all of the encoded p48 (NS1-2)
molecules from cluster 1 (Fig. 8) showed amino acid changes ap-
pearing inmultiple isolates, suggesting neutral consequences with
FIG 4 Summary of evolutionary rates inferred for the genomic regions of GII.4 cluster 1. Evolutionary rates were estimated as described in Materials and
Methods, and mean values are indicated by colored circles, and error bars show 95% confidence intervals. The region of the norovirus genome used for
calculation is labeled, and the two regions with rates higher than that of the full genome are in red.
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no constraints to limit change or positive selection (D7V, N15D,
R55K, V79T [or V79A], and S184P). Both MEME and FUBAR
identified p48 (NS1-2) codon 79 as being under positive selection
(Table 6).
DISCUSSION
Our work outlines a strategy for full-genome deep sequencing of
norovirus directly from fecal specimens, and we have applied the
strategy to characterize norovirus samples collected across a clin-
ical spectrum of pediatric norovirus infections in HCMC, Viet-
nam. An essential component of the methods is a primer design
algorithm that takes as input all of the available sequence data for
a virus and quickly provides a set of functional primers. The flex-
ible design of the primer design algorithm avoids a cumbersome
alignment step in the process and facilitates regular updates with
new sequence data. This is essential to avoid perpetuating a bias in
the sequence data whereby sequences are obtained only if primers
have functioned and primers are designed on antiquated data sets.
Themethod showed a high success rate of full-genome sequencing
of GII noroviruses, especially GII.4, which was predictable given
that GII.4 genomes dominated the sequence data set used to de-
FIG 5 Changes in the GII.4 cluster 1 VP1 protein. The protein sequences were aligned, and amino acid differences from the reconstructed ancestral sequence of
cluster 1 were determined and marked with vertical colored bars, with the new amino acid residue color coded as shown at the bottom; the gray bar indicates a
gap in the query sequence. The sequences were ordered by sample date, with the earliest samples at the bottom of the graph. Functional domains of the VP1
protein are indicated at the top of the graph and include the shell domain and the protruding 1 (P1) and protruding 2 (P2) domains. The locations of blockade
epitopes A and E are also indicated (B_A and B_E, respectively). The histogram in the second panel from the top indicates the total number of changes at each
position. The protein changes occurring in more than four samples are annotated with the parental amino acid, the position, and the new amino acid. Codons
found to be under positive selection by MEME or FUBAR are indicated with red asterisks.
TABLE 6 Positive-selection analysis
Codon positiona FUBARb MEMEc
ORF1 (p48 [NS1-2]) 79 0.991 0.037
ORF2 (VP1) 106 0.993 0.014
ORF2 (VP1) 298 0.984 0.05
ORF3 (VP2) 144d 0.983 0.043
a Codons under positive selection in 140 cluster 1 norovirus genomes sequenced in this
study as detected by FUBAR (44) and the MEME (43).
b Posterior probability values obtained by FUBAR are shown.
c P values obtained by MEME are shown.
d The analysis of ORF3 covered the first 247 of the protein’s 268 codons.
Cotten et al.
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sign the primers. Future primer sets will be designed by using
more targeted and updated genome sets and including more se-
quence data from other genogroups.
Results obtained by this method have provided a large set of
norovirus genome sequences derived from longitudinal samples
from one location. At the start of this study, 265 full norovirus
genomeswere available in theGenBank database; this study added
an additional 112 genomes. The data allowed the estimation of
evolutionary rates for several genotypes, for full genomes, as well
as for subgenomic regions. The evolutionary pressures and the
constraints to avoid change are not expected to be uniform across
the virus genome. Selection pressures are likely to vary greatly,
depending on the function of the encoded proteins, with enzy-
matic and structural regions more constrained then surface- and
immune-exposed or spacer regions with less-well-defined func-
tions. The ORF-specific substitution rates estimated for the three
phylogenetic clusters show that the ORF1 regions exhibited evo-
lutionary rates lower than those of the ORF2 (VP1) regions.
Previous studies have estimated that norovirus GII.4 and GII.3
VP1 capsid regions evolve at 5.1 10	3 to 5.8 10	3 substitution
per site per year (49–51), while it was estimated that the GII.4
polymerase region evolve at 4.33 10	3 to 8.98 10	3 substitu-
tion per site per year, depending on the data set used (49). Our
estimates based on HCMC data are consistent with these previ-
ously published values. The evolutionary rate determined for
GII.4 cluster 1 was higher than the estimated rates for GII.4 cluster
4 and the GII.3 cluster 5 viruses, perhaps because of a greater
number of cluster 1 infections per unit of time and thus a greater
number of replication events. Alternatively, the three virus geno-
types might have intrinsically different replication properties,
polymerase fidelity, or immune selection pressure that result in
the differing rates.
The norovirus sequence data obtained from this study allowed
an analysis of the evolutionary patterns of the second viral capsid
protein VP2. The high evolutionary rates reported here (cluster 5,
7.38 10	3 substitution per site per year; cluster 1, 8.99 10	3
FIG 6 Changes in cluster 1 minor capsid protein VP2 over time. Protein changes were analyzed and are depicted as described in the legend to Fig. 5. The
functional domains of the VP2 protein, including the VP1-interacting region (VP1_ID), are marked at the top. The histogram in the second panel from the top
indicates the total number of changes at each position. A codon found to be under positive selection by the MEME or FUBAR is indicated with a red asterisk.
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substitution per site per year) have not been observed previously,
as this region was seldom included in previous sequencing proj-
ects. The structure of VP2 is not defined, although there is evi-
dence that the protein is interior to the VP1 shell and may be
important for assembly of the VP1 structure (52). The protein is
moderately basic, and the C-terminal half of the protein is rich in
serine and threonine residues (providing possible phosphoryla-
tion sites) and proline residues (perhaps accounting for the inabil-
ity to define the structure of this protein). Evidence that changes in
VP2 accompany changes in VP1 has been presented (48). Re-
cently, MNV VP2 has been shown to influence the host immune
response to the virus, with MNV1 VP2 interfering with antigen-
presenting cell function and MNV3 VP2 promoting the response
(53). These observations identify a possible site of virus-host in-
teraction that could be a source of selective pressure. The evolu-
tionary rates of the VP2-encoding regions were found here to be
much higher than that of the well-studied norovirus VP1 region,
and the higher rates are consistent with a less constrained protein
product, stronger selection pressures, or both. Positive-selection
analysis across the VP2 region identified position 144 as being
under selection; this region of the protein was previously found to
be involved in interactions of VP2 with VP1 (52). A high evolu-
tionary rate in a virus capsid protein suggests a region of the virion
experiencing immune selection. Vaccine development efforts
should take this accelerated rate of change into consideration
when selecting components for a vaccine.
Humoral immunity to norovirus (at least GII.4) may involve
blockade antibodies that bind andblock theVP1 residues required
for binding to HBGAs (16, 54, 55). The correlation of high-titer
blockade antibodies with protection from gastroenteritis in chal-
lenge studies (29) and the frequent evolution of these sites (block-
ade epitopes A, D, and E) suggest that these amino acid residues
may be frequent targets of immune selection (55). Blockade
epitope D may be directly involved in HBGA binding (16, 54).
Our observation of changes in VP1 position 298 epitope A, posi-
tion 393 epitope D, and position 412 epitope E supports these
FIG 7 Changes in cluster 1 p22 (NS4) proteins over time. Protein changes were analyzed and are depicted as described in the legend to Fig. 5. The functional
domains of the p22 (NS4) protein, including theMERES domain, aremarked at the top. The histogram in the second panel from the top shows the total number
of changes at each position.
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previous conclusions. Several additional changes were located
outside the blockade epitopes (S78G, S174P, G340E, and T502N,
Fig. 5). Further studies should investigate whether these are
founder effect changes of neutral consequence or if they provide
an advantage for the virus.
Similarmean evolutionary rates for full genomeswere found in
clusters 1, 4, and 5, with 95% confidence interval ranges largely
overlapping. One might expect a higher evolutionary rate for
GII.4 viruses than for GII.3 viruses if the 10-fold higher detection
frequency thanGII.3 viruses directly reflects the community prev-
alence of these two infections. The similar full-genome rates sug-
gest that either the number of active infections is not a large factor
in the rate or that the less frequently diagnosedGII.3 infection is as
frequent in the population as GII.4 but does not appear as fre-
quently in clinics.
The ORF1-encoded p22 (NS4) regions showed a higher evolu-
tionary rate than the full genome, and p48 (NS1-2) codon 79 was
found to be under positive selection. The function of p22 (NS4) is
not known, but the protein has been observed to localize to the
Golgi compartment/endoplasmic reticulum (ER) and influence
the host secretory pathway with a centrally located MERES
(mimic of an ER export signal)motif required for localization (56,
57). The function of p48 (NS1-2) in norovirus infection is also
largely unexplored, although the protein is reported to localize to
vesicles and has been proposed to influence protein trafficking
(58). The evidence that these viral proteins interact with host pro-
teins, combined with the higher evolutionary rate or positive se-
lection described here, suggests that these proteins may interact
with host restriction factors. Alternatively, these regions with
higher rates of change could encode proteins with no constraint.
Further studies are needed to clarify this.
Extensive work has been done with the feline calicivirus and
MNV models to elucidate the roles and interactions of the non-
structural (NS1-7) and structural (VP1 and VP2) proteins in the
regulation of virus replication and infectivity, as comprehensively
reviewed in reference 1. However, functional profiling of human
FIG 8 Changes in cluster 1 p48 (NS1-2) proteins over time. Protein changes were analyzed and are depicted as described in the legend to Fig. 5. The functional
domains of the p48 (NS1-2) protein, including the transmembrane (TM) domain, are marked at the top. The histogram in the second panel from the top shows
the total number of changes at each position. A codon found to be under positive selection by the MEME or FUBAR is indicated with a red asterisk.
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norovirus is not yet possible because of the lack of tissue culture
and animal models for human norovirus replication. The full-
genome sequences of human norovirus available from this study
provide valuable data on the spectrum of changes in the viral
proteins allowed by the virus while awaiting alternativemodels for
functional experiments.
This study has provided a description of norovirus evolution
rates across HCMC over a 2.5-year period for the full genome, as
well as for subgenomic regions, of the virus.We reveal for the first
time a higher evolutionary rate in three regions of the genome
(VP2, p22 [NS4], and p48 [NS1-2]) and provide evidence of pos-
itive selection in two coding regions (VP2 and p48 [NS1-2]). We
suggest that these regions should be monitored for interactions
with the host that might be a source of selective pressure. Finally,
we believe that this study and the methods we have described will
provide a useful template for community-wide studies of the full-
genome evolution of many RNA virus pathogens.
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